Busch Matthew C. 4
Research Summary
AI-generated summary
Amgen VP & CAO Matthew Busch Sells 41 Shares for Tax Withholding
What Happened
- Matthew C. Busch, Vice President, Finance & Chief Accounting Officer of Amgen Inc. (AMGN), had 41 shares disposed on May 7, 2026 to satisfy tax withholding obligations related to equity awards. The shares were priced at $331.11 each for a gross value of about $13,576.
Key Details
- Transaction date: 2026-05-07
- Type: Tax withholding / payment of tax liability (Form 4 code F)
- Shares disposed: 41 at $331.11 per share (total ≈ $13,576)
- Footnote: 39 of these shares represent Dividend Equivalents credited to unvested Restricted Stock Units under Amgen’s equity plan; DEs are paid in shares on a one-to-one basis per the vesting schedule, with cash for fractional shares.
- Shares owned after transaction: not disclosed in the provided filing excerpt
- Filing timeliness: Report filed 2026-05-11 (within the Form 4 two-business-day requirement)
Context
- This was a routine tax-withholding transaction tied to equity compensation (DEs/RSUs), not an open-market purchase or a discretionary sale for investment purposes. Such withholdings are common when awards vest or dividend equivalents are credited and generally reflect administrative tax obligations rather than a trading signal.